The COVID-19 pandemic has affected all surgical specialties, including oral maxillofacial surgery. While many surgical procedures can be delayed without having as grave an impact on a patient’s quality of life, this is not always the case for Head and Neck Cancer.

This activity addresses how the COVID-19 pandemic affects oral and maxillofacial surgeons who perform in head and neck oncology and microvascular reconstruction surgery. To gain an in-depth perspective on the impact of the pandemic for this surgical team, Head and Neck Oncology and Microvascular Reconstruction Surgeons from geographic locations across the country discuss how the COVID-19 Pandemic is affecting their practice patterns. Specifically:

  • Local & hospital policies
  • Did COVID-19 change any of their practice patterns?
  • Surgical Workup
  • Participation at Tumor Board
  • Operating day
  • Anesthesia
  • Surgical team, PPE used
  • Head and neck ablative procedure
  • Reconstruction procedure
  • Microvascular procedure
  • Post-operative head and neck care

Each participating presenter gives the audience an idea of the number of COVID-19 infection at their states and their hospital systems they work at, number of ICU beds, and ventilator capacities. Both academic and private practice surgeons are represented to compare and contrast their experience during this Pandemic.

Course Co-Chairs

Thomas Schlieve, DDS, MD
Assistant Professor, UT Southwestern Medical Center,
Director of the Residency Training Program and Medical Director, Department of Oral and Maxillofacial Surgery, Parkland Hospital
Dallas, TX
Waleed Zaid, DDS, MSc, FRCD(c), FACS
Associate Professor, Louisiana State University Health Sciences Center – New Orleans
Oral and Maxillofacial Surgery Department – School of Dentistry
Baton Rouge Site Director
Chief of Dentistry/OMFS, Our Lady of the Lake
Baton Rouge, LA

Learning Objectives

  1. Review evidenced-based guidelines for Head and Neck High risk procedures
  2. Discuss Preoperative workflow and modifications needed
  3. Describe Intraoperative modification in the COVID-19 era
  4. Explain Immediate & Post-operative management of head and neck patients
  5. Discuss the future of Head and Neck Surgery in the coming year and what to expect

Schedule
The live webinar took place on May 9, 2020.

10:00 AM – 10:30 AM Perspectives in Head and Neck Surgery Volume during the COVID-19 Pandemic
All Faculty
10:30 AM – 11:00 AM Preoperative Work Up & Tumor Board during COVID-19
Donita Dyalarm, DDS, MD, MD, FACS; Michael R. Markiewicz, DDS, MD, MPH, FACS
11:00 AM – 11:30 AM High Risk Procedures and Operative Room Flow
Arshad Kaleem, DDS, MD; Anthony Mortlandt, DDS, MD, FACS; Melvyn Yeoh, MD, DMD, FACS
11:30 AM – 12:00 PM Proper Personal Protective Equipment / PPE fof Head and Neck and Major Surgery
Jasjit Dillon, DDS, MBBS, FDSRCS, FACS; Ashish Patel, DDS, MD, FACS; Chi Viet, DDS, PhD, MD
12:00 PM – 12:20 PM Break
12:20 PM – 12:30 PM Sponsored Presentation by KLS Martin
Not eligible for CDE
12:30 PM – 1:00 PM Non-Oral Cavity Head and Neck Cancers (Salivary gland, Laryngeal and Endocrine)
Srinivasa Chandra, DDS, MD; Beomjune (BJ) Kim DMD, MD, FACS; Ketan Patel, DDS, PhD
1:00 PM – 1:30 PM Modifications in your Practice and Short-term Implications
Thomas Schlieve, DDS, MD; Waleed Zaid, DDS, MSc, FRCD(c), FACS
1:30 PM – 1:45 PM Questions and Answers

Method of Participation:
To participate in this activity, participants must (1) read the CDE information, including target audience, learning objectives, and disclosure statements, (2) view the educational activity, (3) complete the post-test assessment questions, and (4) complete the activity evaluation. A CDE certificate will be issued after completion of the activity.

Target Audience: This activity is intended for head and neck surgeons and oral and maxillofacial surgeons.

Continuing Dental Education:
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. This activity has been approved for 3.25 hours of Continuing Dental Education (CDE) credit.

This activity is supported by an educational grant from KLS Martin.

Financial Disclosure
It is the policy of ACOMS to ensure balance, independence, objectivity and scientific rigor in all its sponsored educational programs. As a continuing education provider accredited by ADA CERP, any planner or faculty in a position to influence educational content is required to disclose the existence of any financial interest or other personal relationship with the manufacturer(s) of any commercial product(s).

The following faculty have relevant relationships to disclose:

  • Jasjit Dillon MD, DDS, BDS, FDSRCS receives grant/research support from OMS Foundation and OsteoScience
  • Donita Dyalram, DDS, MD, FACS serves on the speaker’s bureau at Stryker and Axogen
  • Arshad Kaleem, DDS, MD serves on the speaker’s bureau at Axogen
  • Michael R. Markiewicz ,DDS, MD, MPH, FACS serves on the speaker’s bureau at Axogen
  • Anthony Morlandt, DDS, MD, FACS receives grant research support at Profeucyte AI and Tactile Medical
  • Ashish Patel, DDS, MD, FACS serves on the speaker’s bureau at Axogen

The following faculty reported no relevant relationships to disclose:

  • Srinivasa Chandra, DDS, MD
  • Beomjune (BJ) B. Kim, DMD, MD, FACS
  • Ashish Patel DDS, MD, FACS
  • Ketan Patel DDS, PhD
  • Thomas Schlieve DDS, MD, FACS
  • Chi Viet DDS, PhD, MD
  • Melvyn Yeoh, MD, DMD, FACS
  • Waleed Zaid DDS, MSc, FRCD(c), FACS

Conflict of Interest Resolution Statement
When individuals who are in a position to control content report financial relationships with one or more commercial interests, ACOMS and PeerPoint Medical Education Institute works with them to resolve such conflicts to ensure that the presented content is free of commercial bias. The content of this program was vetted by an external topic expert to ensure content is evidence-based, fair balanced, does not promote a proprietary business interest, and patient treatment recommendations provide a balanced view of treatment options.